Appeal 2007-0539
Application 10/264,026
20. The pseudopterosin composition of claim 14, and further
comprising a cosmetically acceptable carrier.
33. An extract of non-animal origin comprising at least one
pseudopterosin compound in a concentration that is higher than
pseudopterosin concentrations in coral extracts.
36. The pseudopterosin composition of claim 14, wherein the
Symbiodinium spp. symbiont belongs to phylotype B1.
42. The pseudopterosin composition of claim 14, wherein the
pseudopterosin compound is selected from the group consisting of
pseudopterosins, seco- pseudopterosins, diterpene aglycones, tricyclic
diterpenes, and derivatives thereof.
As defined in the Specification, the term “‘pseudopterosin
compounds’ include[s] natural and synthetic pseudopterosins, seco-
pseudopterosins, diterpene aglycones, and tricyclic diterpenes” (Spec. ¶ 27).
“Derivatives of pseudopterosin compounds include compounds that have
chemical structures and activities that are similar to those compounds
produced by, synthesized in, or isolated from Symbiodinium spp. symbionts
or hosts thereof” (id. at ¶ 28), and “may be synthesized by derivatizing the
various naturally occurring pseudopterosins . . . which are isolated from
Symbiodinium hosts” (id.).
According to the Specification, “[the] distribution of the various
pseudopterosin compounds is likely the result of different environmental
conditions of the areas in which the hosts and symbionts are located” (id. at
¶ 32), and “[t]he symbionts may be the same or different” (id.). “Thus, . . .
different pseudopterosin compounds from a variety of symbionts . . . may be
obtained according to the present invention” (id.). For example, “extracts of
3
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 Next
Last modified: September 9, 2013